调节GluA2-γ5突触复合物脱敏,聚胺阻断和辅助子单元-2的抗抗抑制
Shanti Pal Gangwar1, Laura Y Yen1,2, Maria V Yelshanskaya1
1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.
Nature structural & molecular biology
|August 31, 2023
概括
辅助子单元微调α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 受体复合体,影响神经传递和药物疗效. 了解这些相互作用是治疗等神经系统疾病的关键.
科学领域:
- 神经科学是一个神经科学.
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 具有辅助子单元的AMPA受体 (AMPAR) 的突触综合体对于激发性神经传递至关重要.
- 这些复合体是神经精神和神经系统疾病 (包括) 的治疗点.
研究的目的:
- 阐明GluA2 AMPAR复合体中γ5和-2 (CNIH2) 辅助子单元的结构和功能作用.
- 了解这些子单元如何调节AMPAR功能和药物相互作用.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定老鼠GluA2 AMPAR复合体与老鼠γ5和人类CNIH2的结构.
- 生物物理和功能分析,以评估聚胺阻断剂和药物效力.
主要成果:
- CNIH2 破坏AMPAR 脱敏状态的稳定,并在封闭道中稳定聚胺结合.
- 无论是CNIH2和γ5都减弱了开放通道聚胺块.
- 这些子单元降低了抗药物perampanel的效力.
结论:
- 辅助子单元表现出突触AMPAR复合体结构和功能的分单元依赖微调.
- 这种调节会影响离子通道阻断和全药物抑制.
- 这些发现对于理解特定于大脑区域的神经传递和设计向治疗来说至关重要.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
341
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
341
Antiepileptic Drugs: Glutamate Antagonists
418
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
418
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators
453
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
453
Antiepileptic Drugs: Potassium Channel Activators
210
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
210
Ligand-gated Ion Channels
12.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.4K


